Latest Erythropoietin Stories
PORTLAND, Oregon, March 12, 2015 /PRNewswire/ -- Erythropoietin is a glycoprotein hormone synthesized in the bone marrow that controls and regulates the mechanism of erythropoiesis
PORTLAND, Oregon, January 15, 2015 /PRNewswire/ -- A new report by Allied Market Research titled, "Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography)
LAKE FOREST, Ill., Jan.
RARITAN, N.J. and SAN ANTONIO, Dec.
SAN FRANCISCO, Dec.
A Significant Portion of CKD-ND Patients are Candidates for Oral HIF-PH Inhibitors in Development, According To Findings from Decision Resources Group BURLINGTON, Mass., Dec.
ResearchMoz.us include new market research report " China Recombinant Protein Drug Industry, 2014-2017: Market Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection
Most Nephrologists Believe There Is Some Level of Unmet Need for ESAs in CKD-ND and Dialysis Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.
AllMed webinar provides in-depth review of the latest standard of care for the use of ESAs in the treatment of Chronic Kidney Disease. Portland, OR (PRWEB) August
- The governor of a province or people.